Page 3 - தொடர்புடையது ப்ராடக்ட்ஸ் பயன்பாடுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Answers to Key Questions About Coronavirus Vaccine Kevin Loria Consumer Reports has no financial relationship with advertisers on this site. In a remarkably short period of time less than one year scientists managed to design, create, and test several potential vaccines for SARS-CoV-2, the virus that causes COVID-19. On Dec. 11, the Food and Drug Administration issued the first emergency use authorization for a coronavirus vaccine, the one developed by Pfizer and BioNTech. On Dec. 18, the FDA issued a second emergency authorization, for a vaccine developed by Moderna, which is based on similar technology.  On Feb. 27, the FDA issued a third emergency use authorization, this time for a vaccine developed by Johnson & Johnson. This vaccine is based on a different technology from the other two authorized so far, and provides protection after just one shot. The others require two injections.

New yorkUnited statesUnited kingdomDoran finkMoncef slaouiPaul offitStephen hahnPaul duprexKathleen neuzilVanderbilt vaccine research programUniversity of marylandUniversity of floridaVaccine research groupWashington postUniversity of pittsburghVaccine research